Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
Year: 2013
Type: review
Abstract: and cerebral vessels was related to the severity of cognitive impairment in patients with cerebrovascular disease [13].Also, ALEs have been reported as useful biomarkers of oxidative damage.The Michael adduct of HNE to proteins was found to be signifi cantly elevated in patients with a variety of oxidative stress-based diseases, such as Alzheimer ' s disease [14], chronic pancreatitis [15], obesity and insulin resistance [16], and systemic lupus erythematosus [17].Besides being considered as reliable biomarkers of oxidative damage, as well as as predictors and prognostic factors, more recently, AGEs and ALEs have also been recognized as important pathogenetic factors of some oxidative-based diseases, as supported by the following facts: (1) as pointed out above, a strict correlation between the amount of AGEs/ALEs in tissues and fl uids and disease states has been found, in both animal and human subjects; (2) a substantial amount of literature is now available reporting the molecular and cellular pathogenic mechanisms for the AGEs/ALEs involvement in the onset and progression of diff erent diseases, including atherosclerosis, diabetes, and neurological disorders.The AGE/ALE damaging eff ect is mediated by diff erent Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
Source: Free Radical Research
Institutions: University of Milan, Slovak Academy of Sciences, Institute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences, National Hellenic Research Foundation, Friedrich Schiller University Jena, Vilnius Gediminas Technical University, University of Rzeszów, University of Łódź
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2037948061
